As for other markers of autoimmunity, Cavazzana et al. reported a low prevalence of anti-Sp100 (2.5%) and anti-Gp210 (0.5%) in a study cohort of SSc patients, rates that are comparable with those we observed [34]. Here, NUP210 is linked to systemic sclerosis.